Efficacy and benefit of a 5-FU/salicylic acid preparation in the therapy of common and plantar warts - Systematic literature review and meta-analysis;Wirksamkeit und nutzen eines 5-FU-/salicylsäurehaltigen präparates in der therapie vulgärer und plantarer warzen - Systematische literaturübersicht und metaanalyse

JDDG - Journal of the German Society of Dermatology

Volumn 2, Issue 3, 2004, Pages 187-193

  Zschocke, Ina ^a   Hartmann, Armin ^b   Schlöbe, Andrea ^b   Cummerow, Ralf ^b   Augustin, Matthias ^b  

^a IFKS   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

5 Fluorouracil; Effectiveness; Meta analysis; Systematic review; Verrucae plantares; Verrucae vulgares; Warts

Indexed keywords

FLUOROURACIL; SALICYLIC ACID;

CLINICAL TRIAL; DRUG EFFICACY; DRUG INDICATION; EVIDENCE BASED MEDICINE; GERMANY; HUMAN; META ANALYSIS; REVIEW; VERRUCA PLANTARIS; VERRUCA VULGARIS; WART VIRUS;

EID: 1642286683     PISSN: 16100379     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0353.2004.04703.x     Document Type: Review

References (31)

1. Bunney MH. The treatment of plantar warts with 5-fluorouracil. Br J Dermatol 1973; 89(1): 96-97.
2. Gross GE, Barrasso R (Eds.): Human Papilloma Virus Infection. Ullstein Mosby, Berlin, Wiesbaden, 1997.
3. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19(3): 210-216.
4. Bart BJ, Biglow J, Vance JC, Neveaux JL. Salicylic acid in karaya gum patch as a treatment for verruca vulgaris. J Am Acad Dermatol 1989; 20(1): 74-76.
5. Bunney MH. Wart treatments. Semin in Dermat 1983; 2(2): 101-108.
6. Gibbs S, Harvey I, Sterling JC, Stark R. Local treatments of cutaneous warts. Systematic review. Cochrane Database Syst Rev 2001; (2): CD001 781
7. Mottaz JH, McKeever PJ, Neveaux JL, Zelickson AS. Transdermal delivery of salicylic acid in the treatment of viral papillomas. Int J Dermatol 1988; 27(8): 596-600.
8. Verbov J. How to manage warts. Arch Dis Child 1999; 80: 97-99.
9. Carpenter H. Treatment of plantar warts. Aust Fam Physician 1988; 17(8): 664.
10. Djawari D. Warzenbehandlung bei Kindern. Kinderarzt 1985; 16(6): 876-877.
11. Goncalves JC. 5-Fluorouracil in the treatment of common warts of the hands. A double-blind study. Br J Dermatol 1975; 92(1): 89-91.
12. Goette DK. Topical chemotherapy with 5-fluorouracil. A review. J Am Acad Dermatol 1981; 4(6): 633-649.
13. Logan RA, Zachary CB. Outcome of carbone dioxide laser therapy for persistent cutaneous viral warts. Br J Dermatol 1989; 121(1): 99-105.
14. Grussendorf-Conen EI, Jacobs S, Rubben A, Dethlefsen U. Topical 5% imiquimod long-term treatment of cutaneous warts resistant to standard therapy modalities. Dermatology 2002; 205(2): 139-145.
15. Gibbs S, Harvey I, Sterling JC, Stark R. Local treatments for cutaneous warts. Cochrane Database Syst Rev. 2003; (3): CD001781. Review
16. Augustin M, Siegel A, Heuser A, Vanscheidt W. Chronic leg ulcer: Cost evaluation of two treatment strategies. J Dermatol Treat 1999; 10(1): 21-25.
17. Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999; 282(11): 1054-1060.
18. Schöffski O. Wirtschaftlichkeitsuntersuchungen von Arzneimitteln. In: Kori-Lindner: Pharmakoökonomie in Deutschland. Editio Cantor Aulendorf, 1995: 76-91.
19. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 2001; 135(11): 982-989.
20. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998; 352(9128): 609-613.
21. Pettiti DB. Meta-analysis, decision analysis and cost-effectiveness analysis: Methods for quantitative synthesis in medicine. Oxford University press, New York, 1994.
22. Shadish W, Haddock CK. Combining Estimates of Effect Size. In: Cooper & Hedges: Handbook of Research Synthesis. New York: Russel Sage Foundation, 1994: 261-281.
23. Artese O, Cazzato S, Iezzi D, Palazzi M, Amatetti M. Controlled study: medical therapy (5-fluorouracil, salicylic acid) vs physical therapy (DTC) of warts. Derm Clin 1994; 1.
24. Breitbart EW. Controlled clinical studies of a new wart medication based on fluorouracil. Z Hautkr 1979; 54(19): 853-855.
25. Hursthouse MW. A controlled trial on the use of topical 5-fluorouracil on viral warts. Br J Dermatol 1975; 92(1): 93-96.
26. Katsarou-Katsari A, Papageorgiou M, Stratigos I. Klinische Studie mit 5-Fluorouracil und Salicylsäure bei der Behandlung von Warzen. Notabene medici 1986; 229-230.
27. Meyer-Rohn J, Schmersahl P. External administration of fluorouracil in the management of warts. Z Hautkr 1978; 53(19): 697-700.
28. Schmidt H, Jacobsen FK. Double-blind randomized clinical study on treatment of warts with a fluorouracil-containing topical preparation. Z Hautkr 1981; 56(1): 41-43.
29. Wolff K. Ergebnis einer klinischen Untersuchung von Verrumal® gegen Placebo, doppelblind und randomisiert im Halbseitenversuch. Hermal Internal report - Gutachten 1980; 1-3.
30. Godlee F (Hrsg.): Clinical Evidence: A Compendium of the Best Available Evidence for Effective Health Care London, England, BMJ Publishing Group, American College of Physicians-American Society of Internal Medicine, 1999.
31. Senff H, Reinel D, Matthies C, Witts D. Topical 5-fluorouracil solution in the treatment of warts - clinical experience. Br J Dermatol 1988; 118(3): 409-414.